Patents by Inventor Josef Heuer

Josef Heuer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for reducing morbidity and mortality in critically ill patients
    Publication number: 20050250684
    Abstract: This invention relates to a novel method of reducing the mortality and morbidity in critically ill patients which comprises administering to the patients an effective amount of FGF-19.
    Type: Application
    Filed: September 10, 2003
    Publication date: November 10, 2005
    Applicant: Eli Lilly and Company Patent Division
    Inventors: Josef Heuer, Alexei Kharitonenkov
  • Method for reducing morbidity and mortality in critically ill patients
    Publication number: 20050176631
    Abstract: This invention relates to a novel method of reducing the mortality and morbidity in critically ill patients which comprises administering to the patients an effective amount of FGF-21.
    Type: Application
    Filed: January 8, 2003
    Publication date: August 11, 2005
    Inventors: Josef Heuer, Alexei Kharitonenkov
  • Extracellular junctional adhesion molecules
    Publication number: 20050159587
    Abstract: This invention provides human extracellular junctional adhesion molecules (huJAM) and polynucleotides which identify and encode huJAM. The invention further provides methods using the molecules of the invention for treating, cancer and inflammatory, immune system, and cardiovascular disorders.
    Type: Application
    Filed: July 5, 2002
    Publication date: July 21, 2005
    Inventors: Josef Heuer, Rosamund Smith, Eric Su